UA110329C2 - Conjugates of fatty acids and niacin and their use - Google Patents

Conjugates of fatty acids and niacin and their use

Info

Publication number
UA110329C2
UA110329C2 UAA201203931A UAA201203931A UA110329C2 UA 110329 C2 UA110329 C2 UA 110329C2 UA A201203931 A UAA201203931 A UA A201203931A UA A201203931 A UAA201203931 A UA A201203931A UA 110329 C2 UA110329 C2 UA 110329C2
Authority
UA
Ukraine
Prior art keywords
niacin
conjugates
fatty acids
effective amount
fatty acid
Prior art date
Application number
UAA201203931A
Other languages
English (en)
Ukrainian (uk)
Inventor
Jill C Milne
Michael R Jirousek
Jean E Bemis
Chi B Vu
Original Assignee
Catabasis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catabasis Pharmaceuticals Inc filed Critical Catabasis Pharmaceuticals Inc
Priority claimed from PCT/US2010/047262 external-priority patent/WO2011028689A1/en
Publication of UA110329C2 publication Critical patent/UA110329C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA201203931A 2009-09-01 2010-08-31 Conjugates of fatty acids and niacin and their use UA110329C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23890309P 2009-09-01 2009-09-01
PCT/US2010/047262 WO2011028689A1 (en) 2009-09-01 2010-08-31 Fatty acid niacin conjugates and their uses

Publications (1)

Publication Number Publication Date
UA110329C2 true UA110329C2 (en) 2015-12-25

Family

ID=55171911

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201203931A UA110329C2 (en) 2009-09-01 2010-08-31 Conjugates of fatty acids and niacin and their use

Country Status (1)

Country Link
UA (1) UA110329C2 (ru)

Similar Documents

Publication Publication Date Title
MY158504A (en) Fatty acid niacin conjugates and their uses
MY160249A (en) Fatty acid fumarate derivatives and their uses
CY1119596T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
PH12013501319A1 (en) Fatty acid acetylated salicylates and their uses
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
CY1119730T1 (el) Παραγωγα καρβοξυλικου οξεος πυρρολιδινης ως αγωνιστες του συζευγμενου με πρωτεϊνή-g υποδοχεα 43 (gpr43), φαρμακευτικη συνθεση και μεθοδοι για χρηση στην αντιμετωπιση μεταβολικων διαταραχων
UA113165C2 (xx) Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
MX2012003555A (es) Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
MX2022009942A (es) Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
EP3682875A3 (en) Methods of treating pediatric metabolic syndrome
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
CY1115725T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
BR112013020586A2 (pt) Uso de células derivadas de tecido do cordão umbilical
WO2014107730A3 (en) Use of fatty acid niacin conjugates for treating diseases
BR112012007888A2 (pt) "métodos de tratamento usando anticorpos anti-ldl oxidada".
EP4302825A3 (en) Pharmaceutical compositions for treatment of inappetence
BR112012006070A2 (pt) composições e métodos para tratar distúrbios convulsivos.
BR112014016450A2 (pt) composto antagonista de leucotrieno b4
WO2013033602A3 (en) Fatty acid amides, compositions and methods of use
UA110329C2 (en) Conjugates of fatty acids and niacin and their use
BRPI1008207A2 (pt) "composição farmacêutica para tratamento de efeitos colateriais por administração de spiegelmers."